NCT07032389View on ClinicalTrials.gov

A Polypill for Acute Coronary Syndrome

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

August 1, 2029

Study Completion Date

August 1, 2029

Conditions
Acute Coronary Syndrome
Interventions
COMBINATION_PRODUCT

Polypill

The polypill is an inert capsule designed to combine multiple individual medications into a convenient, once-daily pill. In this case it will include DAPT and a statin.

Trial Locations (1)

75209

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Texas Southwestern Medical Center

OTHER